ATE538109T1 - NEW 2-(2-HYDROXYPHENYL)BENZOTHIADIAZINE SUITABLE FOR THE TREATMENT OF OBESITY AND DIABETES - Google Patents
NEW 2-(2-HYDROXYPHENYL)BENZOTHIADIAZINE SUITABLE FOR THE TREATMENT OF OBESITY AND DIABETESInfo
- Publication number
- ATE538109T1 ATE538109T1 AT07822643T AT07822643T ATE538109T1 AT E538109 T1 ATE538109 T1 AT E538109T1 AT 07822643 T AT07822643 T AT 07822643T AT 07822643 T AT07822643 T AT 07822643T AT E538109 T1 ATE538109 T1 AT E538109T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- diabetes
- treatment
- benzothiadiazine
- hydroxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200601488 | 2006-11-15 | ||
PCT/EP2007/062408 WO2008059025A1 (en) | 2006-11-15 | 2007-11-15 | Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE538109T1 true ATE538109T1 (en) | 2012-01-15 |
Family
ID=39016016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07822643T ATE538109T1 (en) | 2006-11-15 | 2007-11-15 | NEW 2-(2-HYDROXYPHENYL)BENZOTHIADIAZINE SUITABLE FOR THE TREATMENT OF OBESITY AND DIABETES |
Country Status (6)
Country | Link |
---|---|
US (1) | US8022066B2 (en) |
EP (1) | EP2086951B1 (en) |
AT (1) | ATE538109T1 (en) |
CA (1) | CA2669874A1 (en) |
ES (1) | ES2377322T3 (en) |
WO (1) | WO2008059025A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008059023A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
ATE523497T1 (en) | 2006-11-15 | 2011-09-15 | High Point Pharmaceuticals Llc | NEW 2-(2-HYDROXYPHENYL)BENZIMIDAZOLES SUITABLE FOR THE TREATMENT OF OBESITAS AND DIABETES |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
LT3565806T (en) | 2017-01-06 | 2022-06-10 | Rivus Pharmaceuticals, Inc. | Novel phenyl derivatives |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3251837A (en) * | 1962-09-14 | 1966-05-17 | Pfizer & Co C | Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides |
US3269955A (en) * | 1963-05-10 | 1966-08-30 | American Cyanamid Co | Method for emitting fluorescent light using fluorescent quinazolones |
US3526627A (en) * | 1969-06-05 | 1970-09-01 | American Cyanamid Co | Method for preparation of quinazolones |
JPS6025984A (en) | 1983-07-22 | 1985-02-08 | Tokyo Inst Of Technol | Preparation of benzothiazine derivative |
US5240962A (en) * | 1991-04-15 | 1993-08-31 | Takasago Institute For Interdisciplinary Science, Inc. | Antiobesity and fat-reducing agents |
CA2241567A1 (en) | 1996-01-17 | 1997-07-24 | Novo Nordisk A/S | Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
JP2000514041A (en) | 1996-07-26 | 2000-10-24 | ドクター・レディーズ・リサーチ・ファウンデーション | Thiazolidinedione compounds having anti-diabetic, hypolipidemic and anti-hypertensive properties, their preparation, and their pharmaceutical compositions |
CA2468374C (en) | 1996-08-30 | 2010-12-21 | Novo-Nordisk A/S | Glp-1 derivatives |
AU4345297A (en) | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
ES2199366T3 (en) | 1996-12-31 | 2004-02-16 | Dr. Reddy's Laboratories Ltd. | HETEROCICLICAL COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED ILLNESSES. |
JP2001518069A (en) | 1997-05-02 | 2001-10-09 | ドクター・レディーズ・リサーチ・ファウンデーション | Novel anti-diabetic compounds having low lipid and anti-hypertensive properties, methods for their preparation and pharmaceutical compositions containing them |
JP2003514508A (en) | 1997-07-01 | 2003-04-15 | ノボ ノルディスク アクティーゼルスカブ | Glucagon antagonist / adverse agent |
US6613942B1 (en) | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
HUP0003999A3 (en) | 1997-07-16 | 2003-03-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them |
US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
WO1999019313A1 (en) | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
JP4391597B2 (en) | 1997-12-02 | 2009-12-24 | ドクター・レディーズ・ラボラトリーズ・リミテッド | Thiazolinedione and oxazolidinedione derivatives with antidiabetic, hypolipidemic and antihypertensive properties |
JP2002527516A (en) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their production and use |
WO2000023416A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
AU6190299A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
JP2002527520A (en) | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their production and use |
EP1123269A1 (en) | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
AU6190199A (en) | 1998-10-21 | 2000-05-08 | Dr. Reddy's Research Foundation | New compounds, their preparation and use |
CZ20011831A3 (en) | 1998-12-18 | 2001-10-17 | Novo Nordisk A/S | Condensed 1,2,4-thiadiazine derivatives; process of their preparation and use |
WO2000041121A1 (en) | 1999-01-07 | 2000-07-13 | Ccrewards.Com | Method and arrangement for issuance and management of digital coupons and sales offers |
JP2002534512A (en) | 1999-01-15 | 2002-10-15 | ノボ ノルディスク アクティーゼルスカブ | Non-peptide GLP-1 agonist |
AU3957800A (en) | 1999-04-16 | 2000-11-02 | Dr. Reddy's Research Foundation | Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate |
MXPA01010472A (en) | 1999-04-16 | 2002-05-06 | Reddy Research Foundation | Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them. |
WO2000063191A1 (en) | 1999-04-16 | 2000-10-26 | Dr. Reddy's Research Foundation | Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
JP2002542237A (en) | 1999-04-20 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their production and use |
AU3958100A (en) | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
WO2000063196A1 (en) | 1999-04-20 | 2000-10-26 | Novo Nordisk A/S | New compounds, their preparation and use |
JP2002542218A (en) | 1999-04-20 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their manufacture and use |
JP2003531856A (en) | 2000-05-02 | 2003-10-28 | スミスクライン・ビーチャム・コーポレイション | Phosphate transport inhibitors |
US6790569B2 (en) | 2000-06-13 | 2004-09-14 | Eastman Kodak Company | Color photothermographic elements comprising phenolic thermal solvents |
DK1305301T3 (en) | 2000-07-20 | 2005-10-17 | Hoffmann La Roche | Alpha-acyl and alpha-heteroatom-substituted benzeneacetamide glucokinase activators |
JP2004067629A (en) | 2002-08-09 | 2004-03-04 | Yamanouchi Pharmaceut Co Ltd | Mitochondria function-activating agent and new benzimidazole derivative |
AU2003275939A1 (en) | 2002-11-08 | 2004-06-07 | Novo Nordisk A/S | Safe chemical uncouplers for the treatment of obesity |
WO2004065370A1 (en) | 2003-01-23 | 2004-08-05 | Crystalgenomics, Inc. | Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof |
WO2004101505A1 (en) | 2003-05-14 | 2004-11-25 | Novo Nordisk A/S | Novel compounds for treatment of obesity |
US20080009015A1 (en) | 2003-11-21 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Methods for Producing Olfactory Gpcrs |
BRPI0416933A (en) * | 2003-11-25 | 2007-01-16 | Novo Nordisk As | compound, pharmaceutical composition, method for treating a disease, use of a compound, and methods for increasing mitochondrial respiration in a patient, and for reducing the amount of reactive oxygen species in a patient. |
WO2005105785A2 (en) | 2004-05-04 | 2005-11-10 | Novo Nordisk A/S | Indole derivatives for treatment of obesity |
EP1836183A2 (en) * | 2004-12-13 | 2007-09-26 | Galileo Pharmaceuticals, Inc. | Spiro derivatives as lipoxygenase inhibitors |
US7705157B2 (en) * | 2004-12-16 | 2010-04-27 | Symyx Solutions, Inc. | Phenol-heterocyclic ligands, metal complexes, and their uses as catalysts |
WO2008059024A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
ATE523497T1 (en) * | 2006-11-15 | 2011-09-15 | High Point Pharmaceuticals Llc | NEW 2-(2-HYDROXYPHENYL)BENZIMIDAZOLES SUITABLE FOR THE TREATMENT OF OBESITAS AND DIABETES |
WO2008059023A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
-
2007
- 2007-11-15 CA CA002669874A patent/CA2669874A1/en not_active Abandoned
- 2007-11-15 AT AT07822643T patent/ATE538109T1/en active
- 2007-11-15 EP EP07822643A patent/EP2086951B1/en not_active Not-in-force
- 2007-11-15 US US12/515,056 patent/US8022066B2/en not_active Expired - Fee Related
- 2007-11-15 WO PCT/EP2007/062408 patent/WO2008059025A1/en active Application Filing
- 2007-11-15 ES ES07822643T patent/ES2377322T3/en active Active
Also Published As
Publication number | Publication date |
---|---|
US8022066B2 (en) | 2011-09-20 |
EP2086951A1 (en) | 2009-08-12 |
CA2669874A1 (en) | 2008-05-22 |
EP2086951B1 (en) | 2011-12-21 |
ES2377322T3 (en) | 2012-03-26 |
WO2008059025A1 (en) | 2008-05-22 |
US20090325941A1 (en) | 2009-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE523497T1 (en) | NEW 2-(2-HYDROXYPHENYL)BENZIMIDAZOLES SUITABLE FOR THE TREATMENT OF OBESITAS AND DIABETES | |
ATE448230T1 (en) | TRICYCLIC AMIDE DERIVATIVES SUITABLE FOR THE TREATMENT OF OBESITAS | |
ATE429218T1 (en) | PINOLENEIC ACID FOR THE TREATMENT OF OBESITY | |
ATE537168T1 (en) | SUBSTITUTED OXAZOLIDINONES AND THEIR USE | |
ATE526991T1 (en) | COMPOSITIONS AND THEIR USES FOR THE GENETHERAPEUTIC TREATMENT OF BONE DISEASES | |
FR2983199B1 (en) | INHIBITORY CHEMICAL MOLECULES IN THE SPLICE MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICE ANOMALIES. | |
MX2009005935A (en) | Chemical compounds and uses. | |
EA200870385A1 (en) | INHIBITION OF TOXICITY ALPHA-SINUCLEINE | |
EA201171439A1 (en) | ALPHA- (N-SULPHONAMIDO) ACETAMIDE COMPOUND AS A BETA AMYLOID PEPTIDE PRODUCT INHIBITOR | |
ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
ATE478863T1 (en) | HETEROTETRACYCLIC COMPOUNDS AS TPOMIMETICA | |
DE602007002197D1 (en) | WOUND TREATMENT PRODUCT | |
MX2009003981A (en) | Calcium receptor modulating agents. | |
DE602005013116D1 (en) | PYRIDINE COMPOUNDS FOR THE TREATMENT OF PROSTAGLANDIN-MEDIATED DISEASES | |
NO20055741L (en) | New chemical compounds | |
EA200900021A1 (en) | PEPTIDE CONNECTIONS FOR THE TREATMENT OF REFRACTORY EPILEPTIC STATUS | |
NO20081562L (en) | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders | |
WO2006105538A3 (en) | Methods and compositions for treating il-21 related pathologies | |
ATE452134T1 (en) | 4-PIPERAZINYLPYRIMIDINE COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RESPONSIVE TO MODULATION OF THE DOPAMINE D3 RECEPTOR | |
NO20083065L (en) | New N-sulfamoylpiperidinamides for prophylaxis or treatment of obesity and related conditions | |
ATE410166T1 (en) | 4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCINOLINE DERIVATIVES FOR THE TREATMENT OF INFERTILITY | |
ATE538109T1 (en) | NEW 2-(2-HYDROXYPHENYL)BENZOTHIADIAZINE SUITABLE FOR THE TREATMENT OF OBESITY AND DIABETES | |
TW200716132A (en) | Novel chemical compounds | |
ATE399557T1 (en) | SELECTIVE NOREPINEPHRINE REUPPOST INHIBITORS FOR THE TREATMENT OF HOT FLASHES | |
DE602006010737D1 (en) | 3- (4-äÄ4- (4-Ä3- (3,3-DIMETHYL-1-PIPERIDINYL) PROPYLAOXYÜPHINYLÜ-1-PIPERIDINYLCARBONYLü-1-NAPHTHALINYL) PROPANE OR PROPENIC ACID AS H1 AND H3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMABLE AND / OR ALLERGIC DISEASES |